Ever Green Stocks: Sprint Corporation (NYSE:S), Tenet Healthcare Corp. (NYSE:THC), ZAGG Inc (NASDAQ:ZAGG), T-Mobile US, Inc. (NYSE:TMUS), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Citing a need to focus more directly on its core business priorities, Sprint Corporation (NYSE:S) announced it has informed NASCAR it will not extend the title sponsorship of the NASCAR Sprint Cup Series after the current agreement expires at the end of the 2016 season. Sprint Corporation (NYSE:S) shares advanced 4.20% in last trading session and ended the day at $3.97. S Gross Margin is 44.50% and its return on assets is -2.30%. Sprint Corporation (NYSE:S) quarterly performance is -42.04%.

On Dec 04, The board of directors of Tenet Healthcare Corporation (NYSE:THC) has appointed Freda C. Lewis-Hall, M.D., executive vice president and chief medical officer of Pfizer Inc., as a new independent director. Dr. Lewis-Hall becomes the board’s tenth member. On 17 December, Tenet Healthcare Corp. (NYSE:THC) shares advanced 0.17% and was closed at $48.44. THC EPS growth in last 5 year was -32.10%. Tenet Healthcare Corp. (NYSE:THC) year to date (YTD) performance is 15.00%.

Mobile device accessories company ZAGG Inc (NASDAQ:ZAGG) on Wednesday raised its full year 2014 net sales guidance to a range of $250 – $255 million from previous guidance of $225 – $235 million. ZAGG Inc (NASDAQ:ZAGG) belongs to Services sector. Its net profit margin is -2.00% and weekly performance is -7.47%. On last trading day company shares ended up $5.33. ZAGG Inc (NASDAQ:ZAGG) distance from 50-day simple moving average (SMA50) is -7.39%.

T-Mobile US Inc. (NYSE:TMUS) is allowing customers to roll over high-speed data allotments, in the fourth-largest U.S. wireless carrier’s latest marketing push to lure subscribers from Verizon Communications Inc. and AT&T Inc. T-Mobile US, Inc. (NYSE:TMUS) shares increased 2.16% in last trading session and ended the day at $25.10. TMUS Gross Margin is 47.80% and its return on assets is 0.20%. T-Mobile US, Inc. (NYSE:TMUS) quarterly performance is -17.65%.

Ironwood Pharmaceuticals (NASDAQ:IRWD) Director Bryan E. Roberts sold 19,792 shares of the stock in a transaction that occurred on Monday, December 15th. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares advanced 6.30% in last trading session and ended the day at $14.67. IRWD Gross Margin is 70.00% and its return on assets is -57.70%. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) quarterly performance is 14.16%.